1: GO: Molecular Function [Display Chart]
10 input genes in category / 53 annotations before applied cutoff / 18661 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
GO:0051721
|
protein phosphatase 2A binding
|
|
7.188E-7
|
3.810E-5
|
1.736E-4
|
3.810E-5
|
3
|
35
|
2
|
GO:0070016
|
armadillo repeat domain binding
|
|
2.010E-5
|
5.326E-4
|
2.427E-3
|
1.065E-3
|
2
|
13
|
3
|
GO:0019903
|
protein phosphatase binding
|
|
4.978E-5
|
8.795E-4
|
4.008E-3
|
2.638E-3
|
3
|
142
|
4
|
GO:0019902
|
phosphatase binding
|
|
1.128E-4
|
1.254E-3
|
5.713E-3
|
5.980E-3
|
3
|
187
|
5
|
GO:0005516
|
calmodulin binding
|
|
1.183E-4
|
1.254E-3
|
5.713E-3
|
6.269E-3
|
3
|
190
|
6
|
GO:0016005
|
phospholipase A2 activator activity
|
|
1.071E-3
|
9.465E-3
|
4.313E-2
|
5.679E-2
|
1
|
2
|
7
|
GO:0061676
|
importin-alpha family protein binding
|
|
1.607E-3
|
1.065E-2
|
4.851E-2
|
8.516E-2
|
1
|
3
|
8
|
GO:0097200
|
cysteine-type endopeptidase activity involved in execution phase of apoptosis
|
|
1.607E-3
|
1.065E-2
|
4.851E-2
|
8.516E-2
|
1
|
3
|
9
|
GO:0005519
|
cytoskeletal regulatory protein binding
|
|
2.142E-3
|
1.261E-2
|
5.748E-2
|
1.135E-1
|
1
|
4
|
10
|
GO:0004861
|
cyclin-dependent protein serine/threonine kinase inhibitor activity
|
|
6.413E-3
|
3.090E-2
|
1.408E-1
|
3.399E-1
|
1
|
12
|
11
|
GO:0016004
|
phospholipase activator activity
|
|
6.413E-3
|
3.090E-2
|
1.408E-1
|
3.399E-1
|
1
|
12
|
12
|
GO:0060229
|
lipase activator activity
|
|
7.479E-3
|
3.266E-2
|
1.488E-1
|
3.964E-1
|
1
|
14
|
13
|
GO:0097153
|
cysteine-type endopeptidase activity involved in apoptotic process
|
|
8.011E-3
|
3.266E-2
|
1.488E-1
|
4.246E-1
|
1
|
15
|
14
|
GO:0008656
|
cysteine-type endopeptidase activator activity involved in apoptotic process
|
|
1.067E-2
|
3.957E-2
|
1.803E-1
|
5.654E-1
|
1
|
20
|
15
|
GO:0005123
|
death receptor binding
|
|
1.120E-2
|
3.957E-2
|
1.803E-1
|
5.936E-1
|
1
|
21
|
16
|
GO:0016505
|
peptidase activator activity involved in apoptotic process
|
|
1.226E-2
|
4.061E-2
|
1.851E-1
|
6.498E-1
|
1
|
23
|
17
|
GO:0030291
|
protein serine/threonine kinase inhibitor activity
|
|
1.596E-2
|
4.961E-2
|
2.261E-1
|
8.461E-1
|
1
|
30
|
18
|
GO:0001786
|
phosphatidylserine binding
|
|
1.755E-2
|
4.961E-2
|
2.261E-1
|
9.300E-1
|
1
|
33
|
19
|
GO:0016538
|
cyclin-dependent protein serine/threonine kinase regulator activity
|
|
1.913E-2
|
4.961E-2
|
2.261E-1
|
1.000E0
|
1
|
36
|
20
|
GO:0004190
|
aspartic-type endopeptidase activity
|
|
1.913E-2
|
4.961E-2
|
2.261E-1
|
1.000E0
|
1
|
36
|
21
|
GO:0070001
|
aspartic-type peptidase activity
|
|
1.966E-2
|
4.961E-2
|
2.261E-1
|
1.000E0
|
1
|
37
|
Show 16 more annotations
|
2: GO: Biological Process [Display Chart]
10 input genes in category / 393 annotations before applied cutoff / 18623 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
GO:0051645
|
Golgi localization
|
|
2.018E-5
|
3.556E-3
|
2.330E-2
|
7.930E-3
|
2
|
13
|
2
|
GO:0048313
|
Golgi inheritance
|
|
2.354E-5
|
3.556E-3
|
2.330E-2
|
9.249E-3
|
2
|
14
|
3
|
GO:0048308
|
organelle inheritance
|
|
2.715E-5
|
3.556E-3
|
2.330E-2
|
1.067E-2
|
2
|
15
|
|
3: GO: Cellular Component [Display Chart]
10 input genes in category / 62 annotations before applied cutoff / 19061 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
GO:0043197
|
dendritic spine
|
|
7.659E-7
|
2.503E-5
|
1.179E-4
|
4.749E-5
|
4
|
151
|
2
|
GO:0044309
|
neuron spine
|
|
8.073E-7
|
2.503E-5
|
1.179E-4
|
5.005E-5
|
4
|
153
|
3
|
GO:0000159
|
protein phosphatase type 2A complex
|
|
4.683E-5
|
8.835E-4
|
4.164E-3
|
2.904E-3
|
2
|
20
|
4
|
GO:0098794
|
postsynapse
|
|
5.700E-5
|
8.835E-4
|
4.164E-3
|
3.534E-3
|
4
|
449
|
5
|
GO:1903293
|
phosphatase complex
|
|
2.994E-4
|
3.094E-3
|
1.458E-2
|
1.856E-2
|
2
|
50
|
6
|
GO:0008287
|
protein serine/threonine phosphatase complex
|
|
2.994E-4
|
3.094E-3
|
1.458E-2
|
1.856E-2
|
2
|
50
|
7
|
GO:0032580
|
Golgi cisterna membrane
|
|
6.735E-4
|
5.966E-3
|
2.811E-2
|
4.176E-2
|
2
|
75
|
8
|
GO:0044307
|
dendritic branch
|
|
1.049E-3
|
8.130E-3
|
3.831E-2
|
6.504E-2
|
1
|
2
|
9
|
GO:0031985
|
Golgi cisterna
|
|
1.193E-3
|
8.219E-3
|
3.873E-2
|
7.397E-2
|
2
|
100
|
10
|
GO:0042585
|
germinal vesicle
|
|
1.573E-3
|
9.183E-3
|
4.327E-2
|
9.754E-2
|
1
|
3
|
11
|
GO:0015629
|
actin cytoskeleton
|
|
1.629E-3
|
9.183E-3
|
4.327E-2
|
1.010E-1
|
3
|
476
|
12
|
GO:0005795
|
Golgi stack
|
|
2.065E-3
|
1.067E-2
|
5.028E-2
|
1.280E-1
|
2
|
132
|
13
|
GO:0001674
|
female germ cell nucleus
|
|
3.144E-3
|
1.499E-2
|
7.066E-2
|
1.949E-1
|
1
|
6
|
14
|
GO:0000137
|
Golgi cis cisterna
|
|
4.190E-3
|
1.732E-2
|
8.161E-2
|
2.598E-1
|
1
|
8
|
15
|
GO:0032059
|
bleb
|
|
4.190E-3
|
1.732E-2
|
8.161E-2
|
2.598E-1
|
1
|
8
|
16
|
GO:0031264
|
death-inducing signaling complex
|
|
4.713E-3
|
1.826E-2
|
8.606E-2
|
2.922E-1
|
1
|
9
|
17
|
GO:0001520
|
outer dense fiber
|
|
5.757E-3
|
2.100E-2
|
9.895E-2
|
3.570E-1
|
1
|
11
|
18
|
GO:0033391
|
chromatoid body
|
|
7.322E-3
|
2.522E-2
|
1.189E-1
|
4.540E-1
|
1
|
14
|
19
|
GO:0005938
|
cell cortex
|
|
8.109E-3
|
2.646E-2
|
1.247E-1
|
5.028E-1
|
2
|
266
|
20
|
GO:0099568
|
cytoplasmic region
|
|
1.191E-2
|
3.538E-2
|
1.667E-1
|
7.387E-1
|
2
|
325
|
21
|
GO:0098791
|
Golgi subcompartment
|
|
1.199E-2
|
3.538E-2
|
1.667E-1
|
7.431E-1
|
2
|
326
|
22
|
GO:0031984
|
organelle subcompartment
|
|
1.306E-2
|
3.681E-2
|
1.734E-1
|
8.097E-1
|
2
|
341
|
23
|
GO:0043073
|
germ cell nucleus
|
|
1.408E-2
|
3.795E-2
|
1.788E-1
|
8.729E-1
|
1
|
27
|
24
|
GO:0030133
|
transport vesicle
|
|
1.557E-2
|
4.022E-2
|
1.895E-1
|
9.653E-1
|
2
|
374
|
25
|
GO:0005874
|
microtubule
|
|
1.991E-2
|
4.836E-2
|
2.279E-1
|
1.000E0
|
2
|
426
|
26
|
GO:0005801
|
cis-Golgi network
|
|
2.028E-2
|
4.836E-2
|
2.279E-1
|
1.000E0
|
1
|
39
|
Show 21 more annotations
|
4: Human Phenotype [Display Chart]
2 input genes in category / 41 annotations before applied cutoff / 4707 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
HP:0012749
|
Focal T2 hypointense brainstem lesion
|
|
1.274E-3
|
1.045E-2
|
4.497E-2
|
5.225E-2
|
1
|
3
|
2
|
HP:0011513
|
Retinal cavernous angioma
|
|
1.274E-3
|
1.045E-2
|
4.497E-2
|
5.225E-2
|
1
|
3
|
3
|
HP:0030430
|
Neuroma
|
|
1.274E-3
|
1.045E-2
|
4.497E-2
|
5.225E-2
|
1
|
3
|
4
|
HP:0007797
|
Retinal vascular malformation
|
|
1.274E-3
|
1.045E-2
|
4.497E-2
|
5.225E-2
|
1
|
3
|
5
|
HP:0012748
|
Focal T2 hyperintense brainstem lesion
|
|
1.274E-3
|
1.045E-2
|
4.497E-2
|
5.225E-2
|
1
|
3
|
6
|
HP:0007872
|
Choroidal hemangioma
|
|
1.699E-3
|
1.161E-2
|
4.996E-2
|
6.966E-2
|
1
|
4
|
7
|
HP:0012747
|
Abnormal brainstem MRI signal intensity
|
|
2.124E-3
|
1.244E-2
|
5.352E-2
|
8.707E-2
|
1
|
5
|
8
|
HP:0006576
|
Hepatic vascular malformations
|
|
2.972E-3
|
1.354E-2
|
5.827E-2
|
1.219E-1
|
1
|
7
|
9
|
HP:0012721
|
Venous malformation
|
|
2.972E-3
|
1.354E-2
|
5.827E-2
|
1.219E-1
|
1
|
7
|
10
|
HP:0002572
|
Episodic vomiting
|
|
1.017E-2
|
4.171E-2
|
1.795E-1
|
4.171E-1
|
1
|
24
|
Show 5 more annotations
|
5: Mouse Phenotype [Display Chart]
6 input genes in category / 285 annotations before applied cutoff / 10355 genes in category
|
6: Domain [Display Chart]
10 input genes in category / 53 annotations before applied cutoff / 18735 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
IPR013258
|
Striatin N
|
InterPro
|
7.691E-7
|
2.037E-5
|
9.284E-5
|
4.076E-5
|
2
|
3
|
2
|
PF08232
|
Striatin
|
Pfam
|
7.691E-7
|
2.037E-5
|
9.284E-5
|
4.076E-5
|
2
|
3
|
3
|
PF09727
|
CortBP2
|
Pfam
|
1.538E-6
|
2.037E-5
|
9.284E-5
|
8.150E-5
|
2
|
4
|
4
|
IPR019131
|
Cortactin-binding p2 N
|
InterPro
|
1.538E-6
|
2.037E-5
|
9.284E-5
|
8.150E-5
|
2
|
4
|
5
|
IPR015470
|
Caspase 3
|
InterPro
|
5.338E-4
|
3.327E-3
|
1.516E-2
|
2.829E-2
|
1
|
1
|
6
|
IPR009652
|
PDCD10
|
InterPro
|
5.338E-4
|
3.327E-3
|
1.516E-2
|
2.829E-2
|
1
|
1
|
7
|
IPR020472
|
G-protein beta WD-40 rep
|
InterPro
|
8.940E-4
|
3.327E-3
|
1.516E-2
|
4.738E-2
|
2
|
85
|
8
|
PF02063
|
MARCKS
|
Pfam
|
1.067E-3
|
3.327E-3
|
1.516E-2
|
5.657E-2
|
1
|
2
|
9
|
SM01292
|
N1221
|
SMART
|
1.067E-3
|
3.327E-3
|
1.516E-2
|
5.657E-2
|
1
|
2
|
10
|
PS00826
|
MARCKS 1
|
PROSITE
|
1.067E-3
|
3.327E-3
|
1.516E-2
|
5.657E-2
|
1
|
2
|
11
|
PF07923
|
N1221
|
Pfam
|
1.067E-3
|
3.327E-3
|
1.516E-2
|
5.657E-2
|
1
|
2
|
12
|
IPR002101
|
MARCKS
|
InterPro
|
1.067E-3
|
3.327E-3
|
1.516E-2
|
5.657E-2
|
1
|
2
|
13
|
PS00827
|
MARCKS 2
|
PROSITE
|
1.067E-3
|
3.327E-3
|
1.516E-2
|
5.657E-2
|
1
|
2
|
14
|
SM01293
|
DUF3402
|
SMART
|
1.067E-3
|
3.327E-3
|
1.516E-2
|
5.657E-2
|
1
|
2
|
15
|
IPR012486
|
N1221
|
InterPro
|
1.067E-3
|
3.327E-3
|
1.516E-2
|
5.657E-2
|
1
|
2
|
16
|
PF11882
|
DUF3402
|
Pfam
|
1.067E-3
|
3.327E-3
|
1.516E-2
|
5.657E-2
|
1
|
2
|
17
|
IPR021819
|
DUF3402
|
InterPro
|
1.067E-3
|
3.327E-3
|
1.516E-2
|
5.657E-2
|
1
|
2
|
18
|
IPR019775
|
WD40 repeat CS
|
InterPro
|
3.273E-3
|
8.988E-3
|
4.096E-2
|
1.735E-1
|
2
|
164
|
19
|
PF03637
|
Mob1 phocein
|
Pfam
|
3.731E-3
|
8.988E-3
|
4.096E-2
|
1.977E-1
|
1
|
7
|
20
|
IPR005301
|
MOB kinase act fam
|
InterPro
|
3.731E-3
|
8.988E-3
|
4.096E-2
|
1.977E-1
|
1
|
7
|
21
|
1.20.140.30
|
-
|
Gene3D
|
3.731E-3
|
8.988E-3
|
4.096E-2
|
1.977E-1
|
1
|
7
|
22
|
SM01388
|
Mob1 phocein
|
SMART
|
3.731E-3
|
8.988E-3
|
4.096E-2
|
1.977E-1
|
1
|
7
|
23
|
PS01121
|
CASPASE HIS
|
PROSITE
|
5.857E-3
|
1.161E-2
|
5.292E-2
|
3.104E-1
|
1
|
11
|
24
|
PS01122
|
CASPASE CYS
|
PROSITE
|
6.388E-3
|
1.161E-2
|
5.292E-2
|
3.386E-1
|
1
|
12
|
25
|
IPR002138
|
Pept C14 p10
|
InterPro
|
6.388E-3
|
1.161E-2
|
5.292E-2
|
3.386E-1
|
1
|
12
|
26
|
IPR016129
|
Caspase his AS
|
InterPro
|
6.388E-3
|
1.161E-2
|
5.292E-2
|
3.386E-1
|
1
|
12
|
27
|
IPR033139
|
Caspase cys AS
|
InterPro
|
6.388E-3
|
1.161E-2
|
5.292E-2
|
3.386E-1
|
1
|
12
|
28
|
PS50207
|
CASPASE P10
|
PROSITE
|
6.388E-3
|
1.161E-2
|
5.292E-2
|
3.386E-1
|
1
|
12
|
29
|
IPR015917
|
Pept C14A
|
InterPro
|
6.919E-3
|
1.161E-2
|
5.292E-2
|
3.667E-1
|
1
|
13
|
30
|
SM00115
|
CASc
|
SMART
|
6.919E-3
|
1.161E-2
|
5.292E-2
|
3.667E-1
|
1
|
13
|
31
|
PS50208
|
CASPASE P20
|
PROSITE
|
7.449E-3
|
1.161E-2
|
5.292E-2
|
3.948E-1
|
1
|
14
|
32
|
IPR029030
|
Caspase-like dom
|
InterPro
|
7.449E-3
|
1.161E-2
|
5.292E-2
|
3.948E-1
|
1
|
14
|
33
|
IPR001309
|
Pept C14 p20
|
InterPro
|
7.449E-3
|
1.161E-2
|
5.292E-2
|
3.948E-1
|
1
|
14
|
34
|
3.40.50.1460
|
-
|
Gene3D
|
7.449E-3
|
1.161E-2
|
5.292E-2
|
3.948E-1
|
1
|
14
|
35
|
PF00400
|
WD40
|
Pfam
|
7.963E-3
|
1.206E-2
|
5.495E-2
|
4.220E-1
|
2
|
259
|
36
|
SM00320
|
WD40
|
SMART
|
8.505E-3
|
1.207E-2
|
5.502E-2
|
4.508E-1
|
2
|
268
|
37
|
IPR001680
|
WD40 repeat
|
InterPro
|
8.751E-3
|
1.207E-2
|
5.502E-2
|
4.638E-1
|
2
|
272
|
38
|
PS00678
|
WD REPEATS 1
|
PROSITE
|
9.126E-3
|
1.207E-2
|
5.502E-2
|
4.837E-1
|
2
|
278
|
39
|
PS50082
|
WD REPEATS 2
|
PROSITE
|
9.190E-3
|
1.207E-2
|
5.502E-2
|
4.871E-1
|
2
|
279
|
40
|
PS50294
|
WD REPEATS REGION
|
PROSITE
|
9.190E-3
|
1.207E-2
|
5.502E-2
|
4.871E-1
|
2
|
279
|
41
|
IPR024858
|
Golgin A
|
InterPro
|
9.569E-3
|
1.207E-2
|
5.502E-2
|
5.071E-1
|
1
|
18
|
42
|
PF15070
|
GOLGA2L5
|
Pfam
|
9.569E-3
|
1.207E-2
|
5.502E-2
|
5.071E-1
|
1
|
18
|
43
|
IPR017986
|
WD40 repeat dom
|
InterPro
|
1.036E-2
|
1.277E-2
|
5.820E-2
|
5.492E-1
|
2
|
297
|
44
|
2.130.10.10
|
-
|
Gene3D
|
1.290E-2
|
1.537E-2
|
7.002E-2
|
6.836E-1
|
2
|
333
|
45
|
IPR015943
|
WD40/YVTN repeat-like dom
|
InterPro
|
1.305E-2
|
1.537E-2
|
7.002E-2
|
6.915E-1
|
2
|
335
|
Show 40 more annotations
|
7: Pathway [Display Chart]
5 input genes in category / 106 annotations before applied cutoff / 12450 genes in category
|
8: Pubmed [Display Chart]
10 input genes in category / 3492 annotations before applied cutoff / 38193 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
18782753
|
A PP2A phosphatase high density interaction network identifies a novel striatin-interacting phosphatase and kinase complex linked to the cerebral cavernous malformation 3 (CCM3) protein.
|
Pubmed
|
2.725E-19
|
9.515E-16
|
8.312E-15
|
9.515E-16
|
7
|
46
|
2
|
23277359
|
HectD1 E3 ligase modifies adenomatous polyposis coli (APC) with polyubiquitin to promote the APC-axin interaction.
|
Pubmed
|
4.786E-16
|
8.356E-13
|
7.300E-12
|
1.671E-12
|
5
|
13
|
3
|
19156129
|
An integrated workflow for charting the human interaction proteome: insights into the PP2A system.
|
Pubmed
|
8.728E-14
|
8.398E-11
|
7.336E-10
|
3.048E-10
|
6
|
107
|
4
|
24366813
|
Interaction proteome of human Hippo signaling: modular control of the co-activator YAP1.
|
Pubmed
|
9.619E-14
|
8.398E-11
|
7.336E-10
|
3.359E-10
|
7
|
270
|
5
|
23455922
|
Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS.
|
Pubmed
|
3.290E-12
|
2.298E-9
|
2.007E-8
|
1.149E-8
|
7
|
446
|
6
|
24255178
|
Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.
|
Pubmed
|
4.950E-10
|
2.881E-7
|
2.517E-6
|
1.728E-6
|
6
|
446
|
7
|
18571342
|
WD-40 repeat protein SG2NA has multiple splice variants with tissue restricted and growth responsive properties.
|
Pubmed
|
6.170E-8
|
2.693E-5
|
2.353E-4
|
2.155E-4
|
2
|
2
|
8
|
11251078
|
Molecular cloning and characterization of phocein, a protein found from the Golgi complex to dendritic spines.
|
Pubmed
|
6.170E-8
|
2.693E-5
|
2.353E-4
|
2.155E-4
|
2
|
2
|
9
|
11319234
|
A mammalian homolog of yeast MOB1 is both a member and a putative substrate of striatin family-protein phosphatase 2A complexes.
|
Pubmed
|
1.851E-7
|
7.181E-5
|
6.273E-4
|
6.463E-4
|
2
|
3
|
10
|
15345747
|
Phosphoproteomic analysis of the developing mouse brain.
|
Pubmed
|
2.899E-7
|
1.012E-4
|
8.843E-4
|
1.012E-3
|
4
|
236
|
11
|
10748158
|
Zinedin, SG2NA, and striatin are calmodulin-binding, WD repeat proteins principally expressed in the brain.
|
Pubmed
|
3.701E-7
|
1.175E-4
|
1.026E-3
|
1.292E-3
|
2
|
4
|
12
|
25743393
|
CCM-3/STRIPAK promotes seamless tube extension through endocytic recycling.
|
Pubmed
|
6.167E-7
|
1.657E-4
|
1.447E-3
|
2.154E-3
|
2
|
5
|
13
|
18502210
|
The armadillo repeat domain of the APC tumor suppressor protein interacts with Striatin family members.
|
Pubmed
|
6.167E-7
|
1.657E-4
|
1.447E-3
|
2.154E-3
|
2
|
5
|
14
|
10681496
|
WD40 repeat proteins striatin and S/G(2) nuclear autoantigen are members of a novel family of calmodulin-binding proteins that associate with protein phosphatase 2A.
|
Pubmed
|
9.250E-7
|
2.153E-4
|
1.881E-3
|
3.230E-3
|
2
|
6
|
15
|
25531779
|
STRIPAK components determine mode of cancer cell migration and metastasis.
|
Pubmed
|
9.250E-7
|
2.153E-4
|
1.881E-3
|
3.230E-3
|
2
|
6
|
16
|
20332113
|
CCM3/PDCD10 stabilizes GCKIII proteins to promote Golgi assembly and cell orientation.
|
Pubmed
|
1.295E-6
|
2.826E-4
|
2.469E-3
|
4.521E-3
|
2
|
7
|
17
|
29587143
|
A Golgi Lipid Signaling Pathway Controls Apical Golgi Distribution and Cell Polarity during Neurogenesis.
|
Pubmed
|
2.773E-6
|
5.697E-4
|
4.977E-3
|
9.685E-3
|
2
|
10
|
18
|
29467281
|
The MYO6 interactome reveals adaptor complexes coordinating early endosome and cytoskeletal dynamics.
|
Pubmed
|
4.038E-6
|
6.762E-4
|
5.907E-3
|
1.410E-2
|
3
|
125
|
19
|
24384391
|
Dual function of Yap in the regulation of lens progenitor cells and cellular polarity.
|
Pubmed
|
4.067E-6
|
6.762E-4
|
5.907E-3
|
1.420E-2
|
2
|
12
|
20
|
20223754
|
The PCP genes Celsr1 and Vangl2 are required for normal lung branching morphogenesis.
|
Pubmed
|
4.067E-6
|
6.762E-4
|
5.907E-3
|
1.420E-2
|
2
|
12
|
21
|
27471260
|
Apoptosis regulates endothelial cell number and capillary vessel diameter but not vessel regression during retinal angiogenesis.
|
Pubmed
|
4.067E-6
|
6.762E-4
|
5.907E-3
|
1.420E-2
|
2
|
12
|
22
|
27436040
|
Gestational stress induces the unfolded protein response, resulting in heart defects.
|
Pubmed
|
4.805E-6
|
7.627E-4
|
6.663E-3
|
1.678E-2
|
2
|
13
|
23
|
21880782
|
Cell dynamics in fetal intestinal epithelium: implications for intestinal growth and morphogenesis.
|
Pubmed
|
5.605E-6
|
8.510E-4
|
7.434E-3
|
1.957E-2
|
2
|
14
|
24
|
30228103
|
Secretory pathway calcium ATPase 1 (SPCA1) controls mouse neural tube closure by regulating cytoskeletal dynamics.
|
Pubmed
|
7.390E-6
|
1.075E-3
|
9.392E-3
|
2.580E-2
|
2
|
16
|
25
|
16512683
|
140 mouse brain proteins identified by Ca2+-calmodulin affinity chromatography and tandem mass spectrometry.
|
Pubmed
|
8.006E-6
|
1.118E-3
|
9.769E-3
|
2.796E-2
|
3
|
157
|
26
|
23533177
|
Lis1 mediates planar polarity of auditory hair cells through regulation of microtubule organization.
|
Pubmed
|
1.421E-5
|
1.808E-3
|
1.580E-2
|
4.963E-2
|
2
|
22
|
27
|
26383973
|
Rint1 inactivation triggers genomic instability, ER stress and autophagy inhibition in the brain.
|
Pubmed
|
1.698E-5
|
1.808E-3
|
1.580E-2
|
5.928E-2
|
2
|
24
|
28
|
24210661
|
Rbx2 regulates neuronal migration through different cullin 5-RING ligase adaptors.
|
Pubmed
|
2.158E-5
|
1.808E-3
|
1.580E-2
|
7.536E-2
|
2
|
27
|
29
|
26685160
|
The apical ectodermal ridge of the mouse model of ectrodactyly Dlx5;Dlx6-/- shows altered stratification and cell polarity, which are restored by exogenous Wnt5a ligand.
|
Pubmed
|
2.496E-5
|
1.808E-3
|
1.580E-2
|
8.715E-2
|
2
|
29
|
30
|
30022023
|
The potassium channel KCNJ13 is essential for smooth muscle cytoskeletal organization during mouse tracheal tubulogenesis.
|
Pubmed
|
2.496E-5
|
1.808E-3
|
1.580E-2
|
8.715E-2
|
2
|
29
|
31
|
29180572
|
The ATPase activity of Asna1/TRC40 is required for pancreatic progenitor cell survival.
|
Pubmed
|
2.673E-5
|
1.808E-3
|
1.580E-2
|
9.336E-2
|
2
|
30
|
32
|
17540176
|
The tumor suppressor PP2A Abeta regulates the RalA GTPase.
|
Pubmed
|
3.048E-5
|
1.808E-3
|
1.580E-2
|
1.064E-1
|
2
|
32
|
33
|
27802273
|
Fusion of Human Fetal Mesenchymal Stem Cells with "Degenerating" Cerebellar Neurons in Spinocerebellar Ataxia Type 1 Model Mice.
|
Pubmed
|
2.618E-4
|
1.808E-3
|
1.580E-2
|
9.143E-1
|
1
|
1
|
34
|
9512515
|
Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes.
|
Pubmed
|
2.618E-4
|
1.808E-3
|
1.580E-2
|
9.143E-1
|
1
|
1
|
35
|
12169388
|
Enhancement of radiotherapy by oleandrin is a caspase-3 dependent process.
|
Pubmed
|
2.618E-4
|
1.808E-3
|
1.580E-2
|
9.143E-1
|
1
|
1
|
36
|
21151119
|
Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease.
|
Pubmed
|
2.618E-4
|
1.808E-3
|
1.580E-2
|
9.143E-1
|
1
|
1
|
37
|
15033815
|
Glycoxidation of low-density lipoprotein increases TUNEL positivity and CPP32 activation in human coronary cells.
|
Pubmed
|
2.618E-4
|
1.808E-3
|
1.580E-2
|
9.143E-1
|
1
|
1
|
38
|
23376641
|
Myristoylated Alanine-Rich protein Kinase C Substrate (MARCKS) expression modulates the metastatic phenotype in human and murine colon carcinoma in vitro and in vivo.
|
Pubmed
|
2.618E-4
|
1.808E-3
|
1.580E-2
|
9.143E-1
|
1
|
1
|
39
|
15803189
|
Absence of caspase 3 activation in neoplastic cells of nasopharyngeal carcinoma biopsies predicts rapid fatal outcome.
|
Pubmed
|
2.618E-4
|
1.808E-3
|
1.580E-2
|
9.143E-1
|
1
|
1
|
40
|
21038681
|
[Effect of cisplatin on apoptosis of spiral ganglion cell and expression of caspase-3 in mouse cochlea].
|
Pubmed
|
2.618E-4
|
1.808E-3
|
1.580E-2
|
9.143E-1
|
1
|
1
|
41
|
16380626
|
CCM3 mutations are uncommon in cerebral cavernous malformations.
|
Pubmed
|
2.618E-4
|
1.808E-3
|
1.580E-2
|
9.143E-1
|
1
|
1
|
42
|
25451273
|
Surveying genetic variants and molecular phylogeny of cerebral cavernous malformation gene, CCM3/PDCD10.
|
Pubmed
|
2.618E-4
|
1.808E-3
|
1.580E-2
|
9.143E-1
|
1
|
1
|
43
|
12960074
|
Gene expression analysis of prostate hyperplasia in mice overexpressing the prolactin gene specifically in the prostate.
|
Pubmed
|
2.618E-4
|
1.808E-3
|
1.580E-2
|
9.143E-1
|
1
|
1
|
44
|
19013511
|
KIOM-79 prevents apoptotic cell death and AGEs accumulation in retinas of diabetic db/db mice.
|
Pubmed
|
2.618E-4
|
1.808E-3
|
1.580E-2
|
9.143E-1
|
1
|
1
|
45
|
12581734
|
Staurosporine-induced death of MCF-7 human breast cancer cells: a distinction between caspase-3-dependent steps of apoptosis and the critical lethal lesions.
|
Pubmed
|
2.618E-4
|
1.808E-3
|
1.580E-2
|
9.143E-1
|
1
|
1
|
46
|
25909216
|
Deficiency of caspase 3 in tumor xenograft impairs therapeutic effect of measles virus Edmoston strain.
|
Pubmed
|
2.618E-4
|
1.808E-3
|
1.580E-2
|
9.143E-1
|
1
|
1
|
47
|
23531848
|
Overexpression of survivin and caspase 3 in oral carcinogenesis.
|
Pubmed
|
2.618E-4
|
1.808E-3
|
1.580E-2
|
9.143E-1
|
1
|
1
|
48
|
20862502
|
Evidence for anti-angiogenic and pro-survival functions of the cerebral cavernous malformation protein 3.
|
Pubmed
|
2.618E-4
|
1.808E-3
|
1.580E-2
|
9.143E-1
|
1
|
1
|
49
|
28585712
|
A Novel Non-Apoptotic Role of Procaspase-3 in the Regulation of Mitochondrial Biogenesis Activators.
|
Pubmed
|
2.618E-4
|
1.808E-3
|
1.580E-2
|
9.143E-1
|
1
|
1
|
50
|
19056468
|
Excitatory tonus is required for the survival of granule cell precursors during postnatal development within the cerebellum.
|
Pubmed
|
2.618E-4
|
1.808E-3
|
1.580E-2
|
9.143E-1
|
1
|
1
|
Show 45 more annotations
|
9: Interaction [Display Chart]
10 input genes in category / 783 annotations before applied cutoff / 17703 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
int:STK25
|
STK25 interactions
|
|
2.283E-19
|
1.788E-16
|
1.294E-15
|
1.788E-16
|
8
|
55
|
2
|
int:CTTNBP2
|
CTTNBP2 interactions
|
|
4.729E-18
|
1.415E-15
|
1.025E-14
|
3.703E-15
|
7
|
33
|
3
|
int:STK26
|
STK26 interactions
|
|
5.421E-18
|
1.415E-15
|
1.025E-14
|
4.245E-15
|
8
|
80
|
4
|
int:STK24
|
STK24 interactions
|
|
7.375E-18
|
1.444E-15
|
1.045E-14
|
5.774E-15
|
8
|
83
|
5
|
int:CTTNBP2NL
|
CTTNBP2NL interactions
|
|
2.486E-17
|
3.893E-15
|
2.819E-14
|
1.946E-14
|
7
|
41
|
6
|
int:STRIP2
|
STRIP2 interactions
|
|
1.900E-16
|
2.480E-14
|
1.796E-13
|
1.488E-13
|
6
|
20
|
7
|
int:STRIP1
|
STRIP1 interactions
|
|
3.316E-16
|
3.245E-14
|
2.350E-13
|
2.596E-13
|
7
|
58
|
8
|
int:PDCD10
|
PDCD10 interactions
|
|
3.316E-16
|
3.245E-14
|
2.350E-13
|
2.596E-13
|
7
|
58
|
9
|
int:STRN3
|
STRN3 interactions
|
|
7.564E-15
|
6.581E-13
|
4.765E-12
|
5.922E-12
|
7
|
89
|
10
|
int:ZRANB1
|
ZRANB1 interactions
|
|
9.520E-15
|
7.454E-13
|
5.398E-12
|
7.454E-12
|
6
|
36
|
11
|
int:STRN
|
STRN interactions
|
|
1.212E-14
|
7.873E-13
|
5.701E-12
|
9.490E-12
|
7
|
95
|
12
|
int:STRN4
|
STRN4 interactions
|
|
1.212E-14
|
7.873E-13
|
5.701E-12
|
9.490E-12
|
7
|
95
|
13
|
int:MOB4
|
MOB4 interactions
|
|
1.307E-14
|
7.873E-13
|
5.701E-12
|
1.023E-11
|
7
|
96
|
14
|
int:PRDM14
|
PRDM14 interactions
|
|
5.237E-14
|
2.929E-12
|
2.121E-11
|
4.101E-11
|
6
|
47
|
15
|
int:PPP2CA
|
PPP2CA interactions
|
|
3.813E-13
|
1.991E-11
|
1.441E-10
|
2.986E-10
|
8
|
313
|
16
|
int:PPP2CB
|
PPP2CB interactions
|
|
7.472E-13
|
3.657E-11
|
2.648E-10
|
5.850E-10
|
7
|
169
|
17
|
int:STK4
|
STK4 interactions
|
|
1.245E-12
|
5.735E-11
|
4.153E-10
|
9.750E-10
|
6
|
78
|
18
|
int:SPINK2
|
SPINK2 interactions
|
|
1.398E-12
|
6.079E-11
|
4.402E-10
|
1.094E-9
|
5
|
27
|
19
|
int:STK3
|
STK3 interactions
|
|
3.935E-12
|
1.622E-10
|
1.174E-9
|
3.081E-9
|
6
|
94
|
20
|
int:TRAF3IP3
|
TRAF3IP3 interactions
|
|
8.667E-12
|
3.232E-10
|
2.340E-9
|
6.786E-9
|
5
|
38
|
21
|
int:SIKE1
|
SIKE1 interactions
|
|
8.667E-12
|
3.232E-10
|
2.340E-9
|
6.786E-9
|
5
|
38
|
22
|
int:FGFR1OP2
|
FGFR1OP2 interactions
|
|
4.473E-11
|
1.592E-9
|
1.153E-8
|
3.502E-8
|
5
|
52
|
23
|
int:SLMAP
|
SLMAP interactions
|
|
1.533E-10
|
5.219E-9
|
3.779E-8
|
1.200E-7
|
5
|
66
|
24
|
int:PPP2R1A
|
PPP2R1A interactions
|
|
2.658E-10
|
8.673E-9
|
6.280E-8
|
2.081E-7
|
7
|
389
|
25
|
int:RASSF3
|
RASSF3 interactions
|
|
4.522E-10
|
1.416E-8
|
1.026E-7
|
3.541E-7
|
4
|
23
|
26
|
int:ZNF550
|
ZNF550 interactions
|
|
2.084E-9
|
6.276E-8
|
4.545E-7
|
1.632E-6
|
4
|
33
|
27
|
int:PPP2R1B
|
PPP2R1B interactions
|
|
2.276E-9
|
6.601E-8
|
4.780E-7
|
1.782E-6
|
5
|
112
|
28
|
int:YPEL1
|
YPEL1 interactions
|
|
7.258E-9
|
2.030E-7
|
1.470E-6
|
5.683E-6
|
3
|
8
|
29
|
int:MCC
|
MCC interactions
|
|
1.602E-8
|
4.324E-7
|
3.131E-6
|
1.254E-5
|
4
|
54
|
30
|
int:ZNF331
|
ZNF331 interactions
|
|
2.465E-8
|
6.435E-7
|
4.659E-6
|
1.930E-5
|
4
|
60
|
31
|
int:NHSL2
|
NHSL2 interactions
|
|
1.252E-7
|
3.162E-6
|
2.289E-5
|
9.801E-5
|
3
|
19
|
32
|
int:TNIK
|
TNIK interactions
|
|
2.337E-7
|
5.719E-6
|
4.141E-5
|
1.830E-4
|
5
|
282
|
33
|
int:TNFRSF1A
|
TNFRSF1A interactions
|
|
1.892E-6
|
4.490E-5
|
3.251E-4
|
1.482E-3
|
4
|
176
|
34
|
int:CCT8
|
CCT8 interactions
|
|
3.894E-6
|
8.968E-5
|
6.494E-4
|
3.049E-3
|
4
|
211
|
35
|
int:CCT5
|
CCT5 interactions
|
|
4.274E-6
|
9.358E-5
|
6.776E-4
|
3.346E-3
|
4
|
216
|
36
|
int:SNAI3
|
SNAI3 interactions
|
|
4.303E-6
|
9.358E-5
|
6.776E-4
|
3.369E-3
|
2
|
6
|
37
|
int:CCT6A
|
CCT6A interactions
|
|
5.970E-6
|
1.263E-4
|
9.148E-4
|
4.675E-3
|
4
|
235
|
38
|
int:TCP1
|
TCP1 interactions
|
|
6.174E-6
|
1.272E-4
|
9.212E-4
|
4.834E-3
|
4
|
237
|
39
|
int:PKN1
|
PKN1 interactions
|
|
6.381E-6
|
1.281E-4
|
9.276E-4
|
4.996E-3
|
3
|
68
|
40
|
int:DYNLL1
|
DYNLL1 interactions
|
|
6.597E-6
|
1.291E-4
|
9.351E-4
|
5.165E-3
|
4
|
241
|
41
|
int:GIPC1
|
GIPC1 interactions
|
|
9.657E-6
|
1.844E-4
|
1.335E-3
|
7.561E-3
|
3
|
78
|
42
|
int:PKN3
|
PKN3 interactions
|
|
1.042E-5
|
1.943E-4
|
1.407E-3
|
8.161E-3
|
3
|
80
|
43
|
int:CCT2
|
CCT2 interactions
|
|
1.447E-5
|
2.634E-4
|
1.907E-3
|
1.133E-2
|
4
|
294
|
44
|
int:PCOLCE2
|
PCOLCE2 interactions
|
|
1.575E-5
|
2.798E-4
|
2.026E-3
|
1.233E-2
|
2
|
11
|
45
|
int:CCT3
|
CCT3 interactions
|
|
1.608E-5
|
2.798E-4
|
2.026E-3
|
1.259E-2
|
4
|
302
|
46
|
int:DFFB
|
DFFB interactions
|
|
7.220E-5
|
1.203E-3
|
8.710E-3
|
5.653E-2
|
2
|
23
|
47
|
int:LRRCC1
|
LRRCC1 interactions
|
|
7.220E-5
|
1.203E-3
|
8.710E-3
|
5.653E-2
|
2
|
23
|
48
|
int:RAB29
|
RAB29 interactions
|
|
7.874E-5
|
1.284E-3
|
9.301E-3
|
6.165E-2
|
2
|
24
|
49
|
int:ATP6V1C2
|
ATP6V1C2 interactions
|
|
8.556E-5
|
1.367E-3
|
9.900E-3
|
6.700E-2
|
2
|
25
|
50
|
int:SNX24
|
SNX24 interactions
|
|
9.266E-5
|
1.451E-3
|
1.051E-2
|
7.256E-2
|
2
|
26
|
Show 45 more annotations
|
10: Cytoband [Display Chart]
10 input genes in category / 10 annotations before applied cutoff / 34661 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
6q22.2
|
6q22.2
|
|
5.769E-4
|
4.327E-3
|
1.267E-2
|
5.769E-3
|
1
|
2
|
2
|
14q13-q21
|
14q13-q21
|
|
8.653E-4
|
4.327E-3
|
1.267E-2
|
8.653E-3
|
1
|
3
|
3
|
4q34
|
4q34
|
|
1.442E-3
|
4.806E-3
|
1.408E-2
|
1.442E-2
|
1
|
5
|
4
|
2p22.2
|
2p22.2
|
|
4.607E-3
|
1.152E-2
|
3.374E-2
|
4.607E-2
|
1
|
16
|
5
|
7q31
|
7q31
|
|
7.763E-3
|
1.389E-2
|
4.070E-2
|
7.763E-2
|
1
|
27
|
6
|
3q26.1
|
3q26.1
|
|
8.336E-3
|
1.389E-2
|
4.070E-2
|
8.336E-2
|
1
|
29
|
7
|
1p13.2
|
1p13.2
|
|
1.348E-2
|
1.863E-2
|
5.456E-2
|
1.348E-1
|
1
|
47
|
8
|
2q33.1
|
2q33.1
|
|
1.490E-2
|
1.863E-2
|
5.456E-2
|
1.490E-1
|
1
|
52
|
9
|
9q34.11
|
9q34.11
|
|
1.689E-2
|
1.877E-2
|
5.498E-2
|
1.689E-1
|
1
|
59
|
10
|
1p13.3
|
1p13.3
|
|
2.002E-2
|
2.002E-2
|
5.863E-2
|
2.002E-1
|
1
|
70
|
Show 5 more annotations
|
11: Transcription Factor Binding Site [Display Chart]
7 input genes in category / 72 annotations before applied cutoff / 9770 genes in category
|
12: Gene Family [Display Chart]
8 input genes in category / 6 annotations before applied cutoff / 18194 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
1371
|
STRIPAK complex
|
genenames.org
|
4.739E-21
|
2.843E-20
|
6.966E-20
|
2.843E-20
|
7
|
20
|
2
|
696
|
Protein phosphatase 2 regulatory subunits
|
genenames.org
|
1.771E-5
|
5.314E-5
|
1.302E-4
|
1.063E-4
|
2
|
15
|
3
|
647
|
MOB kinase activators
|
genenames.org
|
3.074E-3
|
6.149E-3
|
1.506E-2
|
1.845E-2
|
1
|
7
|
4
|
362
|
Ring finger proteins|WD repeat domain containing
|
genenames.org
|
5.463E-3
|
6.844E-3
|
1.677E-2
|
3.278E-2
|
2
|
262
|
5
|
468
|
Caspases
|
genenames.org
|
5.703E-3
|
6.844E-3
|
1.677E-2
|
3.422E-2
|
1
|
13
|
|
13: Coexpression [Display Chart]
10 input genes in category / 1021 annotations before applied cutoff / 23137 genes in category
|
14: Coexpression Atlas [Display Chart]
10 input genes in category / 566 annotations before applied cutoff / 21829 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
GSM854255 500
|
Myeloid Cells, DC.103-11b+.LuLN, MHCII+ CD11c+ CD8- CD11b+ CD103-, Lymph Node, avg-3
|
Immgen.org, GSE15907
|
5.140E-4
|
3.081E-2
|
2.131E-1
|
2.909E-1
|
3
|
366
|
2
|
GSM854243 500
|
Myeloid Cells, DC.103+11b-.LuLN, MHCII+ CD11c+ CD8- CD11b- CD103+, Lymph Node, avg-3
|
Immgen.org, GSE15907
|
5.560E-4
|
3.081E-2
|
2.131E-1
|
3.147E-1
|
3
|
376
|
3
|
GSM854290 500
|
Myeloid Cells, DC.8-4-11b-.SLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-1
|
Immgen.org, GSE15907
|
5.604E-4
|
3.081E-2
|
2.131E-1
|
3.172E-1
|
3
|
377
|
4
|
GSM538277 500
|
Myeloid Cells, DC.IIhilang-103-11blo.SLN, MHCIIhi CD11c+ Langerin- CD103- CD11b-, Lymph Node, avg-3
|
Immgen.org, GSE15907
|
6.003E-4
|
3.081E-2
|
2.131E-1
|
3.398E-1
|
3
|
386
|
5
|
GSM538268 500
|
Myeloid Cells, DC.IIhilang+103+11blo.SLN, MHCIIhi CD11c+ Langerin+ CD103+ CD11b-, Lymph Node, avg-3
|
Immgen.org, GSE15907
|
6.372E-4
|
3.081E-2
|
2.131E-1
|
3.607E-1
|
3
|
394
|
6
|
GSM605834 500
|
Myeloid Cells, DC.8-4-11b-.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-2
|
Immgen.org, GSE15907
|
6.805E-4
|
3.081E-2
|
2.131E-1
|
3.852E-1
|
3
|
403
|
7
|
GSM854287 500
|
Myeloid Cells, DC.8-4-11b+.SLN, CD11b-FITC CD4-PE CD11c-eFluor780 CD8a-eFluor450 C, Lymph Node, avg-1
|
Immgen.org, GSE15907
|
7.004E-4
|
3.081E-2
|
2.131E-1
|
3.964E-1
|
3
|
407
|
8
|
GSM538274 500
|
Myeloid Cells, DC.IIhilang-103-11b+.SLN, MHCIIhi CD11c+ Langerin- CD103- CD11b+, Lymph Node, avg-3
|
Immgen.org, GSE15907
|
7.206E-4
|
3.081E-2
|
2.131E-1
|
4.079E-1
|
3
|
411
|
9
|
GSM538271 500
|
Myeloid Cells, DC.IIhilang+103-11b+.SLN, MHCIIhi CD11c+ Langerin+ CD103- CD11b+, Lymph Node, avg-3
|
Immgen.org, GSE15907
|
7.257E-4
|
3.081E-2
|
2.131E-1
|
4.107E-1
|
3
|
412
|
10
|
GSM538263 500
|
Myeloid Cells, DC.8-4-11b+.MLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-2
|
Immgen.org, GSE15907
|
7.308E-4
|
3.081E-2
|
2.131E-1
|
4.136E-1
|
3
|
413
|
11
|
GSM538262 500
|
Myeloid Cells, DC.8-4-11b+.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-1
|
Immgen.org, GSE15907
|
7.360E-4
|
3.081E-2
|
2.131E-1
|
4.166E-1
|
3
|
414
|
12
|
GSM605836 500
|
Myeloid Cells, DC.8-4-11b-.MLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-3
|
Immgen.org, GSE15907
|
7.568E-4
|
3.081E-2
|
2.131E-1
|
4.284E-1
|
3
|
418
|
13
|
GSM854291 500
|
Myeloid Cells, DC.8-4-11b-.SLN, CD11b-FITC CD4-PE CD11c-eFluor780 CD8a-eFluor450 C, Lymph Node, avg-3
|
Immgen.org, GSE15907
|
7.568E-4
|
3.081E-2
|
2.131E-1
|
4.284E-1
|
3
|
418
|
14
|
GSM854285 500
|
Myeloid Cells, DC.8-4-11b+.SLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-2
|
Immgen.org, GSE15907
|
7.621E-4
|
3.081E-2
|
2.131E-1
|
4.314E-1
|
3
|
419
|
15
|
Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Nephrogenesis/Kidney Normal fetal kidney Nephrogenesis/Kidney Normal fetal kidney F1
|
Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Nephrogenesis/Kidney Normal fetal kidney Nephrogenesis/Kidney Normal fetal kidney F1
|
Adult, Development, and Cancer types
|
9.160E-4
|
3.456E-2
|
2.391E-1
|
5.185E-1
|
1
|
2
|
16
|
gudmap dev gonad e13.5 M InterstitFLeydig MafB k2 1000
|
dev gonad e13.5 M InterstitFLeydig MafB k-means-cluster#2 top-relative-expression-ranked 1000
|
Gudmap Mouse ST 1.0
|
1.006E-3
|
3.558E-2
|
2.461E-1
|
5.692E-1
|
2
|
105
|
Show 11 more annotations
|
15: Computational [Display Chart]
7 input genes in category / 33 annotations before applied cutoff / 10037 genes in category
|
16: MicroRNA [Display Chart]
10 input genes in category / 609 annotations before applied cutoff / 72241 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
hsa-miR-30e-5p:Functional MTI
|
Functional MTI
|
miRTarbase
|
1.074E-7
|
4.135E-5
|
2.890E-4
|
6.540E-5
|
4
|
347
|
2
|
hsa-miR-30d-5p:Functional MTI
|
Functional MTI
|
miRTarbase
|
1.358E-7
|
4.135E-5
|
2.890E-4
|
8.270E-5
|
4
|
368
|
3
|
hsa-miR-30b-5p:Functional MTI
|
Functional MTI
|
miRTarbase
|
2.215E-7
|
4.496E-5
|
3.142E-4
|
1.349E-4
|
4
|
416
|
4
|
ACACTAC,MIR-142-3P:MSigDB
|
ACACTAC,MIR-142-3P:MSigDB
|
MSigDB
|
5.871E-7
|
8.939E-5
|
6.248E-4
|
3.575E-4
|
3
|
124
|
5
|
hsa-miR-142-3p:PITA
|
hsa-miR-142-3p:PITA TOP
|
PITA
|
2.436E-6
|
2.967E-4
|
2.074E-3
|
1.483E-3
|
3
|
199
|
6
|
GTTTGTT,MIR-495:MSigDB
|
GTTTGTT,MIR-495:MSigDB
|
MSigDB
|
4.061E-6
|
4.122E-4
|
2.881E-3
|
2.473E-3
|
3
|
236
|
7
|
hsa-miR-498:Functional MTI
|
Functional MTI
|
miRTarbase
|
1.010E-5
|
8.785E-4
|
6.140E-3
|
6.149E-3
|
3
|
320
|
8
|
hsa-miR-452:PITA
|
hsa-miR-452:PITA TOP
|
PITA
|
2.808E-5
|
2.137E-3
|
1.494E-2
|
1.710E-2
|
3
|
451
|
9
|
hsa-miR-2053:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
5.283E-5
|
3.553E-3
|
2.483E-2
|
3.218E-2
|
2
|
79
|
10
|
hsa-miR-6889-3p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
5.834E-5
|
3.553E-3
|
2.483E-2
|
3.553E-2
|
2
|
83
|
11
|
hsa-miR-5585-3p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
6.710E-5
|
3.715E-3
|
2.597E-2
|
4.086E-2
|
2
|
89
|
12
|
hsa-miR-4715-3p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
1.082E-4
|
5.493E-3
|
3.840E-2
|
6.592E-2
|
2
|
113
|
13
|
hsa-miR-525-3p:mirSVR highEffct
|
hsa-miR-525-3p:mirSVR nonconserved highEffect-0.5
|
MicroRNA.org
|
1.303E-4
|
5.947E-3
|
4.157E-2
|
7.937E-2
|
2
|
124
|
14
|
hsa-miR-524-3p:mirSVR highEffct
|
hsa-miR-524-3p:mirSVR nonconserved highEffect-0.5
|
MicroRNA.org
|
1.367E-4
|
5.947E-3
|
4.157E-2
|
8.326E-2
|
2
|
127
|
15
|
hsa-miR-770-5p:PITA
|
hsa-miR-770-5p:PITA TOP
|
PITA
|
1.568E-4
|
6.364E-3
|
4.449E-2
|
9.546E-2
|
2
|
136
|
16
|
hsa-miR-33a-3p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
1.806E-4
|
6.767E-3
|
4.730E-2
|
1.100E-1
|
2
|
146
|
17
|
hsa-miR-581:PITA
|
hsa-miR-581:PITA TOP
|
PITA
|
1.906E-4
|
6.767E-3
|
4.730E-2
|
1.161E-1
|
2
|
150
|
18
|
hsa-miR-758:PITA
|
hsa-miR-758:PITA TOP
|
PITA
|
2.035E-4
|
6.767E-3
|
4.730E-2
|
1.239E-1
|
2
|
155
|
19
|
hsa-miR-432:PITA
|
hsa-miR-432:PITA TOP
|
PITA
|
2.168E-4
|
6.767E-3
|
4.730E-2
|
1.320E-1
|
2
|
160
|
20
|
hsa-miR-885-5p:PITA
|
hsa-miR-885-5p:PITA TOP
|
PITA
|
2.305E-4
|
6.767E-3
|
4.730E-2
|
1.404E-1
|
2
|
165
|
21
|
hsa-miR-567:PITA
|
hsa-miR-567:PITA TOP
|
PITA
|
2.333E-4
|
6.767E-3
|
4.730E-2
|
1.421E-1
|
2
|
166
|
22
|
hsa-miR-3680-3p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
2.682E-4
|
7.423E-3
|
5.189E-2
|
1.633E-1
|
2
|
178
|
23
|
hsa-miR-335:PITA
|
hsa-miR-335:PITA TOP
|
PITA
|
2.959E-4
|
7.834E-3
|
5.476E-2
|
1.802E-1
|
2
|
187
|
24
|
hsa-miR-188-5p:PITA
|
hsa-miR-188-5p:PITA TOP
|
PITA
|
3.151E-4
|
7.834E-3
|
5.476E-2
|
1.919E-1
|
2
|
193
|
25
|
hsa-miR-1305:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
3.216E-4
|
7.834E-3
|
5.476E-2
|
1.958E-1
|
2
|
195
|
26
|
hsa-miR-425:PITA
|
hsa-miR-425:PITA TOP
|
PITA
|
3.382E-4
|
7.922E-3
|
5.537E-2
|
2.060E-1
|
2
|
200
|
27
|
hsa-miR-297:PITA
|
hsa-miR-297:PITA TOP
|
PITA
|
4.621E-4
|
1.042E-2
|
7.286E-2
|
2.814E-1
|
2
|
234
|
28
|
GTACTGT,MIR-101:MSigDB
|
GTACTGT,MIR-101:MSigDB
|
MSigDB
|
4.941E-4
|
1.075E-2
|
7.511E-2
|
3.009E-1
|
2
|
242
|
29
|
hsa-miR-136:PITA
|
hsa-miR-136:PITA TOP
|
PITA
|
5.567E-4
|
1.107E-2
|
7.736E-2
|
3.390E-1
|
2
|
257
|
30
|
hsa-miR-194:PITA
|
hsa-miR-194:PITA TOP
|
PITA
|
6.185E-4
|
1.107E-2
|
7.736E-2
|
3.767E-1
|
2
|
271
|
31
|
hsa-miR-142-3p.1:TargetScan
|
hsa-miR-142-3p.1
|
TargetScan
|
6.276E-4
|
1.107E-2
|
7.736E-2
|
3.822E-1
|
2
|
273
|
32
|
ACATTCC,MIR-206:MSigDB
|
ACATTCC,MIR-206:MSigDB
|
MSigDB
|
6.740E-4
|
1.107E-2
|
7.736E-2
|
4.105E-1
|
2
|
283
|
33
|
ACATTCC,MIR-1:MSigDB
|
ACATTCC,MIR-1:MSigDB
|
MSigDB
|
6.740E-4
|
1.107E-2
|
7.736E-2
|
4.105E-1
|
2
|
283
|
34
|
hsa-miR-4789-3p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
7.221E-4
|
1.107E-2
|
7.736E-2
|
4.397E-1
|
2
|
293
|
35
|
hsa-miR-509-3-5p:PITA
|
hsa-miR-509-3-5p:PITA TOP
|
PITA
|
7.269E-4
|
1.107E-2
|
7.736E-2
|
4.427E-1
|
2
|
294
|
36
|
hsa-miR-509-5p:PITA
|
hsa-miR-509-5p:PITA TOP
|
PITA
|
7.269E-4
|
1.107E-2
|
7.736E-2
|
4.427E-1
|
2
|
294
|
37
|
hsa-miR-449a:PITA
|
hsa-miR-449a:PITA TOP
|
PITA
|
7.319E-4
|
1.107E-2
|
7.736E-2
|
4.457E-1
|
2
|
295
|
38
|
hsa-miR-34c-5p:PITA
|
hsa-miR-34c-5p:PITA TOP
|
PITA
|
7.319E-4
|
1.107E-2
|
7.736E-2
|
4.457E-1
|
2
|
295
|
39
|
hsa-miR-34a:PITA
|
hsa-miR-34a:PITA TOP
|
PITA
|
7.319E-4
|
1.107E-2
|
7.736E-2
|
4.457E-1
|
2
|
295
|
40
|
hsa-miR-449b:PITA
|
hsa-miR-449b:PITA TOP
|
PITA
|
7.319E-4
|
1.107E-2
|
7.736E-2
|
4.457E-1
|
2
|
295
|
41
|
hsa-miR-606:PITA
|
hsa-miR-606:PITA TOP
|
PITA
|
7.616E-4
|
1.107E-2
|
7.736E-2
|
4.638E-1
|
2
|
301
|
42
|
hsa-miR-342-3p:Functional MTI
|
Functional MTI
|
miRTarbase
|
7.768E-4
|
1.107E-2
|
7.736E-2
|
4.730E-1
|
2
|
304
|
43
|
hsa-miR-335-3p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
7.818E-4
|
1.107E-2
|
7.736E-2
|
4.761E-1
|
2
|
305
|
44
|
hsa-miR-512-3p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
8.023E-4
|
1.107E-2
|
7.736E-2
|
4.886E-1
|
2
|
309
|
45
|
hsa-miR-1259:PITA
|
hsa-miR-1259:PITA TOP
|
PITA
|
8.178E-4
|
1.107E-2
|
7.736E-2
|
4.980E-1
|
2
|
312
|
46
|
hsa-miR-4438:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
8.920E-4
|
1.181E-2
|
8.254E-2
|
5.432E-1
|
2
|
326
|
47
|
hsa-miR-5589-5p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
9.358E-4
|
1.213E-2
|
8.476E-2
|
5.699E-1
|
2
|
334
|
48
|
hsa-let-7g-5p:Functional MTI
|
Functional MTI
|
miRTarbase
|
9.750E-4
|
1.229E-2
|
8.589E-2
|
5.938E-1
|
2
|
341
|
49
|
hsa-miR-421:PITA
|
hsa-miR-421:PITA TOP
|
PITA
|
1.056E-3
|
1.229E-2
|
8.589E-2
|
6.430E-1
|
2
|
355
|
50
|
hsa-miR-216a:PITA
|
hsa-miR-216a:PITA TOP
|
PITA
|
1.103E-3
|
1.229E-2
|
8.589E-2
|
6.719E-1
|
2
|
363
|
Show 45 more annotations
|
17: Drug [Display Chart]
10 input genes in category / 5564 annotations before applied cutoff / 22841 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
ctd:C471674
|
10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone
|
CTD
|
1.566E-5
|
1.668E-2
|
1.535E-1
|
8.710E-2
|
2
|
14
|
2
|
CID000011496
|
AC1L1XHD
|
Stitch
|
2.338E-5
|
1.668E-2
|
1.535E-1
|
1.301E-1
|
2
|
17
|
3
|
ctd:D004040
|
Dietary Carbohydrates
|
CTD
|
6.513E-5
|
1.668E-2
|
1.535E-1
|
3.624E-1
|
3
|
190
|
4
|
1076 UP
|
ICI 182,780; Up 200; 0.01uM; MCF7; HT HG-U133A EA
|
Broad Institute CMAP Up
|
6.719E-5
|
1.668E-2
|
1.535E-1
|
3.738E-1
|
3
|
192
|
5
|
7001 DN
|
Rapamycin; Down 200; 0.1uM; MCF7; HT HG-U133A
|
Broad Institute CMAP Down
|
6.929E-5
|
1.668E-2
|
1.535E-1
|
3.855E-1
|
3
|
194
|
6
|
5489 DN
|
Prenylamine lactate [69-43-2]; Down 200; 9.6uM; MCF7; HT HG-U133A
|
Broad Institute CMAP Down
|
7.143E-5
|
1.668E-2
|
1.535E-1
|
3.974E-1
|
3
|
196
|
7
|
6372 DN
|
3-nitropropionic acid; Down 200; 10uM; PC3; HT HG-U133A
|
Broad Institute CMAP Down
|
7.252E-5
|
1.668E-2
|
1.535E-1
|
4.035E-1
|
3
|
197
|
8
|
1693 UP
|
Sulindac [38194-50-2]; Up 200; 11.2uM; MCF7; HT HG-U133A
|
Broad Institute CMAP Up
|
7.252E-5
|
1.668E-2
|
1.535E-1
|
4.035E-1
|
3
|
197
|
9
|
2940 DN
|
Methyldopate hydrochloride [2508-79-4]; Down 200; 14.6uM; HL60; HT HG-U133A
|
Broad Institute CMAP Down
|
7.473E-5
|
1.668E-2
|
1.535E-1
|
4.158E-1
|
3
|
199
|
10
|
1542 DN
|
Paclitaxel [33069-62-4]; Down 200; 4.6uM; MCF7; HT HG-U133A
|
Broad Institute CMAP Down
|
7.473E-5
|
1.668E-2
|
1.535E-1
|
4.158E-1
|
3
|
199
|
11
|
CID000164073
|
Pkcs
|
Stitch
|
8.891E-5
|
1.668E-2
|
1.535E-1
|
4.947E-1
|
3
|
211
|
12
|
CID000000684
|
deoxythymidine diphosphate-glucose
|
Stitch
|
9.043E-5
|
1.668E-2
|
1.535E-1
|
5.032E-1
|
2
|
33
|
13
|
CID000208907
|
ladostigil
|
Stitch
|
2.007E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
2
|
49
|
14
|
ctd:C055494
|
caffeic acid phenethyl ester
|
CTD
|
2.875E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
3
|
314
|
15
|
CID006914565
|
AC1OCA7P
|
Stitch
|
3.536E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
2
|
65
|
16
|
CID000114736
|
PDMP
|
Stitch
|
3.757E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
2
|
67
|
17
|
ctd:C018584
|
linalool
|
CTD
|
4.338E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
2
|
72
|
18
|
ctd:C005998
|
dihydroxyfumarate
|
CTD
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
19
|
ctd:C507889
|
polylactide-polyethylene glycol-polylactide
|
CTD
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
20
|
CID000073677
|
stictic acid
|
Stitch
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
21
|
ctd:C512706
|
4-(1-benzenesulfonyl-1H-indol-2-yl)-4-hydroxycyclohexa-2,5-dienone
|
CTD
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
22
|
ctd:C000977
|
dihydroouabain
|
CTD
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
23
|
CID005327325
|
Inhibitor 47a
|
Stitch
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
24
|
CID005327344
|
Inhibitor 55
|
Stitch
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
25
|
ctd:C434652
|
tetrachloroguaiacol
|
CTD
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
26
|
ctd:C494582
|
1H-(1,2,3)oxadiazolo(4,4-a)quinoxalin-1-one
|
CTD
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
27
|
CID000348462
|
methyl 3-oxo-3-phenylpropanoate
|
Stitch
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
28
|
CID010255842
|
5-[[6-[[(2R)-1-carboxy-3-oxopropan-2-yl]amino]-6-oxo-5-thiophen-2-ylhexyl]sulfamoyl]-2-hydroxybenzoic acid
|
Stitch
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
29
|
CID005321083
|
CID5321083
|
Stitch
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
30
|
ctd:C458523
|
BIBR 1532
|
CTD
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
31
|
DB08497
|
(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate
|
Drug Bank
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
32
|
ctd:C044556
|
2-iodomelatonin
|
CTD
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
33
|
DB03124
|
5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid
|
Drug Bank
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
34
|
CID005327345
|
inhibitor 56
|
Stitch
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
35
|
CID000073726
|
diphenylpropane
|
Stitch
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
36
|
CID005327330
|
Inhibitor 69a
|
Stitch
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
37
|
DB08213
|
1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE
|
Drug Bank
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
38
|
CID011632008
|
Isoquinoline-1,3,4-trione 6k
|
Stitch
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
39
|
CID005327316
|
Inhibitor 67a
|
Stitch
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
40
|
DB08251
|
4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID
|
Drug Bank
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
41
|
ctd:C471867
|
4-(benzothiazol-2-yl)-4-hydroxy-2,5-cyclohexadien-1-one
|
CTD
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
42
|
ctd:C530601
|
arsenic triiodide
|
CTD
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
43
|
CID009870833
|
sulfonamide analog 9
|
Stitch
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
44
|
CID005327315
|
Inhibitor 65b
|
Stitch
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
45
|
CID005476815
|
stannic;3-[(1Z,4Z,10Z,14Z)-18-(2-carboxyethyl)-3,7,12,17-tetramethyl-8,13-divinyl-porphine-21,22,23,24-tetraid-2-yl]propionic acid
|
Stitch
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
46
|
CID010459952
|
sulfonamide analog 14
|
Stitch
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
47
|
ctd:C071861
|
inostamycin
|
CTD
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
48
|
ctd:C100269
|
ergocryptine
|
CTD
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
49
|
CID005327339
|
inhibitor 50
|
Stitch
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
50
|
CID005327327
|
Inhibitor 67b
|
Stitch
|
4.378E-4
|
1.668E-2
|
1.535E-1
|
1.000E0
|
1
|
1
|
Show 45 more annotations
|
18: Disease [Display Chart]
9 input genes in category / 306 annotations before applied cutoff / 16205 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
C1864040
|
Cerebral Cavernous Malformations 3
|
DisGeNET Curated
|
1.804E-5
|
5.522E-3
|
3.480E-2
|
5.522E-3
|
2
|
12
|
2
|
C2937358
|
Cerebral Hemorrhage
|
DisGeNET Curated
|
2.115E-4
|
3.237E-2
|
2.040E-1
|
6.473E-2
|
2
|
40
|
3
|
OMIN:603285
|
CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3
|
OMIM
|
5.554E-4
|
3.399E-2
|
2.142E-1
|
1.699E-1
|
1
|
1
|
4
|
C0393971
|
Spinal cord stroke
|
DisGeNET BeFree
|
5.554E-4
|
3.399E-2
|
2.142E-1
|
1.699E-1
|
1
|
1
|
5
|
cv:C1864040
|
Cerebral cavernous malformations 3
|
Clinical Variations
|
5.554E-4
|
3.399E-2
|
2.142E-1
|
1.699E-1
|
1
|
1
|
|
|